Conclusive decision making with our diagnostic kinome activity technology
Our mission is to support oncologists, clinicians and researchers in making conclusive decisions resulting in first time right patient treatment in cancer research. We developed a multiplex kinome activity profiling technology based on next generation kinase science and 15 years of experience to make this possible.
The IOpener™, our diagnostic blood test, provides rapid and non-invasive measurement of real-time cellular kinome activity. Kinases play a crucial role in immune checkpoint regulation and therefore predict patient response before immunotherapy has started. Response or non-response is driven by an individual patient’s kinase profile. Matching the kinase profile to the best therapeutic can dramatically improve patient outcomes and increase survival.
The IOpener™, our diagnostic blood test, provides rapid and non-invasive measurement of real-time cellular kinome activity.Read more
Discovering, analyzing and optimizing therapeutic candidates and their mechanisms of action based on our comprehensive and robust kinase technology providing insights in real-time cell signalingRead more